TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
OCGN

Ocugen Inc

Healthcare · Biotechnology

1.00$ +2.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Ocugen Inc (OCGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 124 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OCGN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
43 36 28 22 16 11 21 15 11 17 15 3.2 24 17 12 24 21 27 54 124 116 106 142 130 116 109 96 89 75 65 52 41 62 82 64 54 58 44 57 124
38 32 25 19 13 8.2 16 9.7 6.0 16 8.1 3.2 23 16 11 23 20 26 51 122 113 103 138 123 107 98 84 73 57 43 30 19 41 62 44 33 38 24 39 107
38 32 16 11 11 7.1 16 8.8 5.2 16 7.4 2.8 15 7.4 3.2 15 19 24 45 116 107 95 130 115 102 78 68 71 53 39 26 16 39 59 38 27 33 19 32 100
38 32 24 19 13 8.0 16 8.8 5.2 16 7.4 2.8 15 7.4 3.2 15 19 24 45 116 107 95 130 115 102 91 77 71 53 39 26 16 39 59 38 27 33 19 32 100
– – – – – – – – – – – – – – – – – – 0.0 -5.0 0.0 5.0 – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – 5.0 5.0 5.0 5.0 – – – – – – – – – – – – – – – – – –
4.3 3.9 3.5 3.1 2.8 2.7 4.4 5.2 4.4 0.1 0.1 0.7 0.2 0.2 0.2 0.5 0.4 1.1 0.8 2.4 2.5 1.2 1.9 3.2 4.5 10.0 8.0 12 – – – – – – – – – – – –
0.2 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
39 23 21 21 21 22 41 39 21 18 20 12 37 5.8 5.0 9.1 6.1 5.8 7.4 7.8 9.2 9.9 11 16 21 35 20 19 16 24 22 24 21 53 49 51 54 56 51 141
7.2 5.2 3.9 3.8 2.9 3.8 8.4 12 8.9 2.9 2.3 0.8 35 4.5 3.3 7.0 4.1 3.6 4.3 4.8 6.2 7.0 7.7 10 15 29 16 13 11 17 16 18 16 22 17 18 20 23 21 133
0.6 0.6 0.6 0.5 0.3 0.2 0.0 – – 8.9 1.1 10 0.2 0.2 0.2 4.2 1.4 0.3 0.5 0.2 0.2 0.4 0.3 0.3 0.4 0.5 1.8 1.8 1.8 0.6 1.9 1.8 1.8 1.8 0.7 0.9 0.9 2.1 5.9 83
1.8 1.9 1.9 1.6 0.8 0.8 1.4 2.2 1.7 1.6 1.1 0.5 5.8 1.9 1.5 0.5 0.2 0.4 1.0 0.8 2.1 2.3 3.9 5.9 6.5 8.1 8.1 3.9 2.9 3.2 1.7 3.4 1.5 4.2 3.2 4.2 4.6 6.2 3.2 5.1
0.3 0.2 0.0 – – – – – – – 1.0 1.0 1.1 1.1 1.6 2.0 1.9 1.8 1.7 1.7 1.7 1.7 1.7 1.8 2.3 2.3 1.1 1.5 1.5 2.8 1.5 1.6 1.6 27 28 28 28 28 24 1.7
4.0 14 7.0 0.8 -4.8 -11 -20 -23 -9.7 -0.5 -5.5 -8.7 -13 11 7.3 15 14 22 46 116 107 96 131 114 95 74 76 70 58 41 30 17 41 30 16 3.1 3.5 -12 5.8 -17
-191 -182 -189 -195 -201 -208 -223 -227 -216 -217 -226 -229 -64 -51 -55 -59 -70 -73 -80 -106 -117 -132 -150 -169 -191 -223 -230 -252 -267 -286 -298 -313 -326 -340 -356 -370 -390 -408 -427 -452
0.2 0.3 0.4 0.4 0.4 0.4 0.5 0.5 0.5 1.3 1.3 1.6 6.4 53 53 84 142 142 186 196 199 199 206 216 217 220 226 238 256 257 257 257 278 291 292 292 304 312 320 339

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?